Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Austco HealthcareASX:AHC 56 EV-to-OCF is 3.61 as of Aug. 09, 2026, which is 56% below its 10-year median of 8.25. GuruFocus rates ASX:AHC with a GF Score™ of 56/100 and a GF Value™ of A$0.36 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Austco Healthcare ranks better than 55.8% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Austco Healthcare's Enterprise Value is A$73.51 Mil.
Austco Healthcare's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$20.36 Mil. Therefore, Austco Healthcare's EV-to-OCF for today is 3.61.
The historical rank and industry rank for Austco Healthcare's EV-to-OCF or its related term are showing as below:
ASX:AHC'
s EV-to-OCF Range Over the Past 10 Years
Min: -9.89 Med: 8.25 Max: 185.94
Current: 3.61
During the past 13 years, the highest EV-to-OCF of Austco Healthcare was 185.94. The lowest was -9.89. And the median was 8.25.
ASX:AHC's EV-to-OCF is ranked better than 55.8% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.82
vs ASX:AHC: 3.61
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Austco Healthcare's PE Ratio (TTM) for today is calculated as:
Austco Healthcare's share price for today is A$0.225.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Austco Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.021.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Austco Healthcare EV-to-OCF Related Terms
Austco Healthcare EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Austco Healthcare's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Austco Healthcare's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Austco Healthcare EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Austco Healthcare's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Austco Healthcare's EV-to-OCF falls into.
Austco Healthcare's current Enterprise Value is A$73.51 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Austco Healthcare's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$20.36 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Austco Healthcare (ASX:AHC) has a EV-to-OCF of 3.61 as of Aug. 09, 2026. This is 56% below median its historical median of 8.25. According to the industry distribution chart, Austco Healthcare ranks #377 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 44.2%.
Is Austco Healthcare's EV-to-OCF too high?
Austco Healthcare's current EV-to-OCF of 3.61 is 56% below median its 10-year median of 8.25. The Medical Devices & Instruments industry median EV-to-OCF is 7.82. Austco Healthcare's value of 3.61 is 53.8% below this industry median. Based on the distribution chart, Austco Healthcare ranks #377 out of 853 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Austco Healthcare has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Austco Healthcare's EV-to-OCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Austco Healthcare ranks #377 out of 853 companies for EV-to-OCF. This puts Austco Healthcare in the upper half of its industry. The industry median EV-to-OCF is 7.82. Austco Healthcare's value of 3.61 is 53.8% below this benchmark. While the company's 10-year median is 8.25 vs. the industry median of 7.82, Austco Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.82, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Austco Healthcare's current EV-to-OCF of 3.61 is 53.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Austco Healthcare's current EV-to-OCF is 3.61, which is 56% below median its own 10-year median of 8.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Austco Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Austco Healthcare (ASX:AHC) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.36, compared to a current price of A$0.23 — trading 37.5% below its estimated fair value. The current EV-to-OCF is 3.61, which is 56% below median its 10-year median of 8.25 and 53.8% below the Medical Devices & Instruments industry median of 7.82. Austco Healthcare's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Austco Healthcare (ASX:AHC), the current EV-to-OCF is 3.61 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Austco Healthcare (ASX:AHC) Overvalued in 2026?
Based on GuruFocus' analysis, Austco Healthcare stock appears to be undervalued.
The current stock price of A$0.23 is trading 37.5% below its estimated GF Value™ of A$0.36.
GuruFocus considers Austco Healthcare to be Possible Value Trap.
Key valuation signals for ASX:AHC:
EV-to-OCF: 3.61 (56% below median its 10-year median of 8.25)
GF Value™: A$0.36 vs. price of A$0.23 (37.5% below fair value)
Industry Position: 53.8% below the Medical Devices & Instruments median (#377 of 853)
No single metric tells the full story. See the ASX:AHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Austco Healthcare Ltd engages in the development and provision of electronic communications and clinical management solutions. It offers Tacera, a nurse call, and healthcare communication system for healthcare professionals and patient. The group is segmented into four geographic regions consisting of Australia/New Zealand, Asia, Europe, and North America.
56GF Score
Get the complete analysis for ASX:AHC
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AHC has been successfully added to your 
